文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 外语学习 > 英语学习 > Molecular diagnosis and therapy of hepatocellularcarcinoma
侵权投诉

Molecular diagnosis and therapy of hepatocellularcarcinoma

科研文献,多多交流

Review

Moleculardiagnosisandtherapyofhepatocellularcarcinoma

(HCC):Anemerging eldforadvancedtechnologies

JensU.Marquardt,PeterR.Galle ,AndreasTeufel

DepartmentofMedicineI,JohannesGutenbergUniversity,Mainz,Germany

Despitegreatprogressindiagnosisandmanagementofhepato-aswellasJapanoverthelast30–50years[2].Notably,confound-cellularcarcinoma(HCC),theexactbiologyofthetumorremainsingfactors,suchasup-streamingimmigrationrates,havepoorlyunderstoodoveralllimitingthepatients’outcome.Detailedconsiderablein uenceonthesenumbersandpresumablytheanalysisandcharacterizationofthemolecularmechanismsandincidencesinUSAandEuropealreadypeakedandstabilizedinsubsequentlyindividualpredictionofcorrespondingprognosticthelastyears,re ectingthedropinhepatitisBinfectionsandtraitswouldrevolutionizebothdiagnosisandtreatmentofHCCimprovedtreatmentmodalitiesagainstinchronichepatitisC,andisthekeygoalofmodernpersonalizedmedicine.OverthewhichconstitutesthepredominantriskfactorinWesterncoun-recentyearssystematicapproachesfortheanalysisofwholetries.Besidesviralhepatitis,otherchronicliverdiseasesduetotumorgenomesandtranscriptomesaswellasepigenomesalcohol,nonalcoholicfattyliverdisease(NAFLD),andothermet-becameaffordabletoolsintranslationalresearch.ThisincludesabolicdisordersarethemainriskfactorsforthedevelopmentofsimultaneousanalysesofthousandsofmoleculartargetsusingHCC.Amongthese,metabolicsyndromeandNAFLDisofparticu-microarray-basedtechnologiesaswellasnext-generationlarinterestinWesterncountriesduetoanalarmingincreaseinsequencing.Althoughcurrentlydiagnosisandclassi cationofprevalenceandhighnumbersofHCCswithoutunderlyingcirrho-hepatocellularcancersstillrelyonhistologicalexaminationofsis[3].

tumorsections,thesetechnologiesshowgreatpromisetoadvanceCurrently,accuratediagnosisoffrankHCCisachievedbythecurrentknowledgeofhepatocarcinogenesis,complementradiologicimagingtechniquessuchascomputertomographydiagnosticclassi cationinasettingofmicroarray-aidedpathol-andmagneticresonanceimaging.Ininconclusivecases,thegoldogy,andrationalizetheindividualdrugselection.Thisreviewaimsstandardstillremainshistology[4].Moredif cultisthepropertosummarizerecentprogressofsystembiologicalapproachesindiagnosisofsmallHCCwhichfrequentlydoesnotpresentwithhepatocarcinogenesisandoutlinepotentialareasfortranslationaltypicalvascularpatternsinimagingtestsandacquisitionofreli-applicationinaclinicalsetting.Further,wegiveanupdateaboutablehistologicalspecimensoftenrequiresrepetitivebiopsiesandknownsignalingpathwaysactiveinHCC,summarizethehistoricalpathologicalinterpretationisdemanding.Therefore,oneoftheapplicationofwholegenomicapproachesinlivercancerandindi-mostchallengingaspectsinhepatologyisthedetectionofprema-cateongoingexperimentalresearchutilizingnoveltechnologiesinlignantlesions[5].

diagnosisandtreatmentofthisdeadlydisease.ThiswillalsoCurativetherapeuticstrategiesforHCCinvolvesurgicalincludethediscussionandcharacterizationofnewmolecularresection,radio-frequencyablationandlivertransplantationandcellulartargetssuchasCancerStemCells(CSCs).[4].Duetolatedetectionandadvancedunderlyingliverdis-Ó2011EuropeanAssociationfortheStudyoftheLiver.Publishedeases,thesetreatmentsareunavailabletothemajorityofthebyElsevierB.V.Allrightsreserved.patients[6].

HCCarehighlyresistanttoconventionalsystemictherapies.

Althoughpromisingnoveltherapiesandtargetsarecurrently

Introductionunderevaluation(doc.guandang.net)theonlysystemicstan-

dardofcareforpatientswithadvancedHCCissorafenibwitha

Hepatocellularcarcinoma(HCC)ranksamongthemostcommonmeansurvivalbene tofonly3months[7–9].cancersworldwideandisthethirdleadingcauseofcancerdeathTherefore,rationalizingandcombiningtargetedtherapiesoverallaccountingformorethanhalfamillionyearlydeaths[1].accordingtogenomicandepigenomicsignaturesofthecorre-AlthoughprevalenceremainshighestinEasternAsiaandAfrica,spondingtumorswillbeakeygoalintranslationaloncologylivercancerincidencesteadilyincreasedintheWesternworldandmightsigni cantlyimprovethetreatmentoflivercancer.

Overthelastdecade,aplethoraofnovelcuttingedgetechnol-

ogiesbecameavailableforcancerresearch.Microarraybased-

Keywords:Livercancer;Molecularpathogenesis;Geneexpressionpro le;Targetapproachesenabledtheaffordableandsystematicanalysisoftherapy.

Received24May2011;receivedinrevisedform7July2011;accepted10July2011thewholecancer(epi-)genomesandtranscriptomes.During Correspondingauthor.Address:DepartmentofMedicineI,JohannesGutenbergthelast10years,detailedcatalogsofsomaticmutationsindiffer-University,Langenbeckstrasse1,55131Mainz,Germany.Tel.:+4906131177275.entcancersweregeneratedandacceleratedtheunderstandingofE-mailaddresses:marquarj@uni-mainz.de(J.U.Marquardt),Galle.peter@carcinogenesis[10,11].Moreover,the-omicsrevolution

Molecular diagnosis and therapy of hepatocellularcarcinoma

re nedunimedizin-mainz.de(P.R.Galle),teufela@uni-mainz.de(A.

Molecular diagnosis and therapy of hepatocellularcarcinoma

Teufel).

JournalofHepatology2012vol.56j

Molecular diagnosis and therapy of hepatocellularcarcinoma

Molecular diagnosis and therapy of hepatocellularcarcinoma

267–275

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email